Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 3/2013

01-03-2013 | Case Report

A case of successful preoperative chemotherapy with cisplatin and irinotecan followed by curative-intent surgery for locally advanced thymic carcinoma

Authors: Shigeki Suzuki, Hirotoshi Horio, Tai Hato, Masahiko Harada, Yusuke Okuma, Tsunekazu Hishima

Published in: General Thoracic and Cardiovascular Surgery | Issue 3/2013

Login to get access

Abstract

The optimal chemotherapy for thymic carcinoma has yet to be determined based on clinical evidence because of the rarity of this pathological entity. We report the case of a patient with locally advanced thymic carcinoma in whom radical excision was achieved with intensive preoperative chemotherapy followed by curative-intent surgery. A 59-year-old woman was diagnosed with Masaoka-Koga stage III thymic cancer showing squamous cell carcinoma histology. Invasion to the ascending aorta and left brachiocephalic vein was suspected from imaging, so preoperative chemotherapy with three cycles of cisplatin and irinotecan was administered. Partial response to chemotherapy was achieved and the residual tumor was completely resected with subsequent surgery. Histopathological examination of the resected specimen demonstrated stage II thymic carcinoma. The patient has shown no evidence of recurrence or surgical complications as of 46 months after completing preoperative chemotherapy.
Literature
1.
go back to reference Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer. 1991;67:1025–32.PubMedCrossRef Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer. 1991;67:1025–32.PubMedCrossRef
2.
go back to reference Hsu CP, Chen CY, Chen CL, Lin CT, Hsu NY, Wang JH, et al. Thymic carcinoma: ten years’ experience in twenty patients. J Thorac Cardiovasc Surg. 1994;107:615–20.PubMed Hsu CP, Chen CY, Chen CL, Lin CT, Hsu NY, Wang JH, et al. Thymic carcinoma: ten years’ experience in twenty patients. J Thorac Cardiovasc Surg. 1994;107:615–20.PubMed
3.
go back to reference Kuo TT, Chang JP, Lin FJ, Wu WC, Chang CH. Thymic carcinomas: histopathological varieties and immunohistochemical study. Am J Surg Pathol. 1991;14:24–34.CrossRef Kuo TT, Chang JP, Lin FJ, Wu WC, Chang CH. Thymic carcinomas: histopathological varieties and immunohistochemical study. Am J Surg Pathol. 1991;14:24–34.CrossRef
4.
go back to reference Shimosato Y, Kameya T, Nagai K, Suemasu K. Squamous cell carcinoma of the thymus. An analysis of eight cases. Am J Surg Pathol. 1977;1:109–21.PubMedCrossRef Shimosato Y, Kameya T, Nagai K, Suemasu K. Squamous cell carcinoma of the thymus. An analysis of eight cases. Am J Surg Pathol. 1977;1:109–21.PubMedCrossRef
5.
go back to reference Travis WD BW, Müller Hermelink HK, Harris CC. World Health Organization classification of tumors. In: Pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004 (Chapter 3). Travis WD BW, Müller Hermelink HK, Harris CC. World Health Organization classification of tumors. In: Pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004 (Chapter 3).
6.
go back to reference Eng TY, Fuller CD, Jagirdar J, Bains Y, Thomas CR Jr. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys. 2004;59:654–64.PubMedCrossRef Eng TY, Fuller CD, Jagirdar J, Bains Y, Thomas CR Jr. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys. 2004;59:654–64.PubMedCrossRef
7.
go back to reference Okuma Y, Hosomi Y, Takagi Y, Iguchi M, Okamura T, Shibuya M. Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity. Lung Cancer. 2011;74:492–6.PubMedCrossRef Okuma Y, Hosomi Y, Takagi Y, Iguchi M, Okamura T, Shibuya M. Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity. Lung Cancer. 2011;74:492–6.PubMedCrossRef
8.
go back to reference Yoh K, Goto K, Ishii G, Niho S, Ohmatsu H, Kubota K, et al. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer. 2003;98:926–31.PubMedCrossRef Yoh K, Goto K, Ishii G, Niho S, Ohmatsu H, Kubota K, et al. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer. 2003;98:926–31.PubMedCrossRef
9.
go back to reference Koizumi T, Takabayashi Y, Yamagishi S, Tsushima K, Takamizawa A, Tsukadaira A, et al. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy). Am J Clin Oncol. 2002;25:266–8.PubMedCrossRef Koizumi T, Takabayashi Y, Yamagishi S, Tsushima K, Takamizawa A, Tsukadaira A, et al. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy). Am J Clin Oncol. 2002;25:266–8.PubMedCrossRef
10.
go back to reference Igawa S, Murakami H, Takahashi T, Nakamura Y, Tsuya A, Naito T, et al. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer. 2010;67:194–7.PubMedCrossRef Igawa S, Murakami H, Takahashi T, Nakamura Y, Tsuya A, Naito T, et al. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer. 2010;67:194–7.PubMedCrossRef
11.
go back to reference Murray N, Shah A, Osoba D, Page R, Karsai H, Grafton C, et al. Intensive weekly chemotherapy for the treatment of extensive stage small cell lung cancer. J Clin Oncol. 1991;9:1632–8.PubMed Murray N, Shah A, Osoba D, Page R, Karsai H, Grafton C, et al. Intensive weekly chemotherapy for the treatment of extensive stage small cell lung cancer. J Clin Oncol. 1991;9:1632–8.PubMed
Metadata
Title
A case of successful preoperative chemotherapy with cisplatin and irinotecan followed by curative-intent surgery for locally advanced thymic carcinoma
Authors
Shigeki Suzuki
Hirotoshi Horio
Tai Hato
Masahiko Harada
Yusuke Okuma
Tsunekazu Hishima
Publication date
01-03-2013
Publisher
Springer Japan
Published in
General Thoracic and Cardiovascular Surgery / Issue 3/2013
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-012-0123-2

Other articles of this Issue 3/2013

General Thoracic and Cardiovascular Surgery 3/2013 Go to the issue